Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard D Lopez

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Immunologic Research|October 31, 2002
Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseasesRichard D Lopez
Blood|August 10, 2013
Inhibiting inhibitory pathways in human γδ T cellsRichard D Lopez
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2005
gammadelta T cells: a new frontier for immunotherapy?Lawrence S Lamb, Richard D Lopez
Journal of Gastroenterology and Hepatology|January 30, 2009
Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancerZhiyong Liu, Ben Guo, Richard D Lopez
International Journal of Hematology|March 4, 2011
Alemtuzumab for the prevention and treatment of graft-versus-host diseaseJunya Kanda, Richard D Lopez, David A Rizzieri
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
An unusual presentation of chronic myelogenous leukemia: a review of isolated central nervous system relapseScott M Lindhorst, Richard D Lopez, Ronald D Sanders
Cancer Immunology, Immunotherapy : CII|January 25, 2002
Down-regulation of IL-2 receptor alpha (CD25) characterizes human gammadelta-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12Ben L Guo, Klaus A Hollmig, Richard D Lopez
Breast Cancer Research and Treatment|September 28, 2005
Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cellsBen L Guo, Zhiyong Liu, Wayne A Aldrich, et al.
The Journal of Urology|April 12, 2005
Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitroZhiyong Liu, Ben L Guo, Bradley C Gehrs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancerZhiyong Liu, Isam-Eldin A Eltoum, Ben Guo, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Immunologic Research|October 31, 2002
Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseasesRichard D Lopez
Blood|August 10, 2013
Inhibiting inhibitory pathways in human γδ T cellsRichard D Lopez
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 4, 2005
gammadelta T cells: a new frontier for immunotherapy?Lawrence S Lamb, Richard D Lopez
Journal of Gastroenterology and Hepatology|January 30, 2009
Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancerZhiyong Liu, Ben Guo, Richard D Lopez
International Journal of Hematology|March 4, 2011
Alemtuzumab for the prevention and treatment of graft-versus-host diseaseJunya Kanda, Richard D Lopez, David A Rizzieri
Journal of the National Comprehensive Cancer Network : JNCCN|July 13, 2013
An unusual presentation of chronic myelogenous leukemia: a review of isolated central nervous system relapseScott M Lindhorst, Richard D Lopez, Ronald D Sanders
Cancer Immunology, Immunotherapy : CII|January 25, 2002
Down-regulation of IL-2 receptor alpha (CD25) characterizes human gammadelta-T cells rendered resistant to apoptosis after CD2 engagement in the presence of IL-12Ben L Guo, Klaus A Hollmig, Richard D Lopez
Breast Cancer Research and Treatment|September 28, 2005
Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cellsBen L Guo, Zhiyong Liu, Wayne A Aldrich, et al.
The Journal of Urology|April 12, 2005
Ex vivo expanded human Vgamma9Vdelta2+ gammadelta-T cells mediate innate antitumor activity against human prostate cancer cells in vitroZhiyong Liu, Ben L Guo, Bradley C Gehrs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2008
Protective immunosurveillance and therapeutic antitumor activity of gammadelta T cells demonstrated in a mouse model of prostate cancerZhiyong Liu, Isam-Eldin A Eltoum, Ben Guo, et al.
Pageof 3